Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00144014 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study in Acute Ischaemic Stroke
A Phase 2 study, sponsored by Vernalis (R&D).
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00144014 is a Phase 2 study that has completed, run by Vernalis (R&D). The registered enrollment target is 49 participants.
The verdict
NCT00144014, a Phase 2 study, has completed, sponsored by Vernalis (R&D).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
Interventions
- DRUG V10153
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00144014
The ClinicalTrials.gov registry entry for NCT00144014 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vernalis (R&D), which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which V10153 is the first listed.
NCT00144014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00144014 about?
NCT00144014 is a clinical study titled "Safety and Efficacy Study in Acute Ischaemic Stroke". A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
What is the current status of trial NCT00144014?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2005-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00144014?
The interventions under investigation include: V10153 (DRUG).
Who is sponsoring clinical trial NCT00144014?
This trial is sponsored by Vernalis (R&D), which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.